Terms: = Lung cancer AND ACSL3, PRO2194, 2181, ENSG00000123983, O95573, FACL3, ACS3 AND Clinical Outcome
1 results:
1. Metabolic enzyme acsl3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer.
Fernández LP; Merino M; Colmenarejo G; Moreno-Rubio J; Sánchez-Martínez R; Quijada-Freire A; Gómez de Cedrón M; Reglero G; Casado E; Sereno M; Ramírez de Molina A
Mol Oncol; 2020 Dec; 14(12):3135-3152. PubMed ID: 33030783
[TBL] [Abstract] [Full Text] [Related]
